​

Funding Round

Series B - Liquidia Technologies

Series B - Liquidia Technologies

Investment Firm

Overview

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

Announced Date

Mar 02, 2007

Closed on Date

Mar 02, 2007

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

New Enterprise Associates

New Enterprise Associates

New Enterprise Associates is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

2

Investor Name
Participant InvestorWakefield Group
Participant InvestorNew Enterprise Associates

Round Details and Background

Liquidia Technologies raised $16000000 on 2007-03-02 in Series B

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

Company Funding History

19

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 13, 2010
Series C - Liquidia Technologies
5-5.0M
Jun 14, 2006
Series A - Liquidia Technologies
7-6.0M
Dec 17, 2009
Grant - Liquidia Technologies
1-3.0M
Jan 19, 2010
Series C - Liquidia Technologies
5-20.0M

Recent Activity

There is no recent news or activity for this profile.